Log in
Enquire now
BerGenBio

BerGenBio

BerGenBio is a target Identification & Small Molecules founded in 2008.

OverviewStructured DataIssuesContributors

All edits by  Haiper 

Edits on 5 Feb, 2022
Haiper profile picture
Haiper
edited on 5 Feb, 2022
Edits made to:
Infobox (+3 properties)
Article (+778 characters)
Table (+5 rows) (+15 cells) (+373 characters)
Article
About

BerGenBio is clinical-stage biopharma developing first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.

Faunding

BerGenBio has raised a total of $150.7M in funding over 8 rounds. Their latest funding was raised on May 5, 2020 from a Post-IPO Equity round.

BerGenBio is registered under the ticker OSE:BGBIO.

...

Their stock opened with NOK25.00 in its Apr 6, 2017 IPO.

BerGenBio is funded by 4 investors. Investinor and Meteva AS are the most recent investors.

Technology

BerGenBio uses 21 technology products and services including HTML5, Google Analytics, and jQuery, according to G2 Stack.

BerGenBio is actively using 20 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and Google Font API.

Table

Name
Role
LinkedIn

Alan Barge

Interim CMO

https://www.linkedin.com/in/alan-barge-b3948b5/

Anthony Brown

CSO

https://www.linkedin.com/in/anthony-brown-9373084/

David Micklem

Co-Founder, CTO ,Director of Biomarkers & Assay Development

https://www.linkedin.com/in/dmicklem

Richard Godfrey

CEO

https://www.linkedin.com/in/richard-godfrey-3928015/

Rune Skeie

CFO

https://www.linkedin.com/in/rune-skeie-68275620/

Infobox
Founded date
2007
Location
Bergen
Bergen
Number of Employees (ranges)
20 – 49

Find more companies like BerGenBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.